Source:http://linkedlifedata.com/resource/pubmed/id/16885342
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2006-8-3
|
pubmed:abstractText |
This study uses a base excision repair (BER)-deficient model, the DNA polymerase beta heterozygous mouse, to investigate the effect of BER deficiency on tumorigenicity and aging. Aged beta-pol(+/-) mice express 50% less beta-pol transcripts and protein (P < 0.05) than aged beta-pol(+/+) mice, showing maintenance of the heterozygous state over the life span of the mouse. This reduction in beta-pol expression was not associated with an increase in mutation rate but was associated with a 100% increase in the onset of hypoploidy. Aged beta-pol(+/-) mice exhibited a 6.7-fold increase in developing lymphoma (P < 0.01). Accordingly, 38% of beta-pol(+/-) mice exhibited lymphoid hyperplasia, whereas none of the beta-pol(+/+) exhibited this phenotype. beta-pol(+/-) mice were also more likely to develop adenocarcinoma (2.7-fold increase; P < 0.05) and more likely to develop multiple tumors, as 20% of the beta-pol(+/-) animals died bearing multiple tumors compared with only 5% of the beta-pol(+/+) animals (P < 0.05). In spite of accelerated tumor development, no gross effect of beta-pol heterozygosity was seen with respect to life span. However, the survival curves for the beta-pol(+/+) and beta-pol(+/-) mice are not identical. A maximum likelihood estimation analysis showed a modest but significant (P < 0.05) acceleration of the age-dependent mortality rate in beta-pol(+/-) mice. Thus, the beta-pol(+/-) mouse represents a model in which mortality rate and tumor development are accelerated and provides evidence supporting the role of genomic maintenance in both aging and carcinogenesis.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/1F32 ES 013643,
http://linkedlifedata.com/resource/pubmed/grant/1P01 AG 14674,
http://linkedlifedata.com/resource/pubmed/grant/1P30 AG 13319,
http://linkedlifedata.com/resource/pubmed/grant/1R21 DK 62256,
http://linkedlifedata.com/resource/pubmed/grant/ES 06639,
http://linkedlifedata.com/resource/pubmed/grant/ES 11044,
http://linkedlifedata.com/resource/pubmed/grant/P01 AG 17242,
http://linkedlifedata.com/resource/pubmed/grant/P01 AG 19316,
http://linkedlifedata.com/resource/pubmed/grant/R01 AG 20438
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0008-5472
|
pubmed:author |
pubmed-author:AnyangweNjwenN,
pubmed-author:BusuttilRita ARA,
pubmed-author:CabelofDiane CDC,
pubmed-author:HeydariAhmad RAR,
pubmed-author:IkenoYujiY,
pubmed-author:MatherlyLarry HLH,
pubmed-author:NyskaAbrahamA,
pubmed-author:RichardsonArlanA,
pubmed-author:TuckerJames DJD,
pubmed-author:VijgJanJ,
pubmed-author:WilsonSamuel HSH
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7460-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16885342-Age Factors,
pubmed-meshheading:16885342-Animals,
pubmed-meshheading:16885342-DNA Damage,
pubmed-meshheading:16885342-DNA Polymerase beta,
pubmed-meshheading:16885342-DNA Repair,
pubmed-meshheading:16885342-Haploidy,
pubmed-meshheading:16885342-Longevity,
pubmed-meshheading:16885342-Male,
pubmed-meshheading:16885342-Mice,
pubmed-meshheading:16885342-Neoplasms, Experimental,
pubmed-meshheading:16885342-Risk Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate.
|
pubmed:affiliation |
Karmanos Cancer Institute, Developmental Therapeutics Program, Wayne State University School of Medicine, 110 East Warren, Detroit, MI 48201, USA. d.cabelof@wayne.edu
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|